Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 15/20 | 0.51 |
| ▸ | PPARA | Q07869 | 12/20 | 0.51 |
| ▸ | PPARD | Q03181 | 8/20 | 0.51 |
| ▸ | CETP | P11597 | 2/20 | 0.41 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.40 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.40 |
| ▸ | MME | P08473 | 1/20 | 0.39 |
| ▸ | ACE | P12821 | 1/20 | 0.39 |
| ▸ | CPA1 | P15085 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | RNF4 | P78317 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5364241 | 0.91 | PPARG (0.43) | PPARGPPARAPPARDPLA2G10PLA2G2A | |
| SCHEMBL5361854 | 0.91 | PPARG (0.59) | PPARGPPARAPPARD | |
| SCHEMBL5358817 | 0.86 | PPARG (0.41) | PPARGPPARAPPARDPLA2G10PLA2G2A | |
| SCHEMBL5364092 | 0.83 | PPARG (0.41) | PPARGPPARAPPARDPLA2G10PLA2G2A | |
| SCHEMBL5364840 | 0.80 | PPARA (0.42) | PPARGPPARAPPARDPLA2G10PLA2G2A | |
| SCHEMBL5364864 | 0.77 | PPARA (0.47) | PPARGPPARAPPARD | |
| SCHEMBL5364805 | 0.77 | PPARG (0.51) | PPARGPPARAPPARD | |
| SCHEMBL5364857 | 0.77 | PPARA (0.65) | PPARGPPARAPPARD | |
| SCHEMBL14366451 | 0.76 | PPARG (0.81) | PPARGPPARAPPARD | |
| SCHEMBL5384053 | 0.76 | PPARG (0.81) | PPARGPPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7220880-B2 | Amide linker peroxisome proliferator activated receptor modulators | ELI LILLY AND COMPANY (US) | 2007-05-22 | — | — | US | disclosed |
| US-20060111406-A1 | Amide linker peroxisome proliferator activated receptor modulators | ELI LILLY AND COMPANY (US) | 2006-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111406-A1 | Amide linker peroxisome proliferator activated receptor modulators | PPARG, PPARA, PPARD | PPARG 1/4885PPARA 2/4885PPARD 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.